John Wilkin
Stock Analyst at Craig-Hallum
(2.68)
# 1,922
Out of 5,124 analysts
5
Total ratings
60%
Success rate
27.13%
Average return
Main Sectors:
Top Industries:
Stocks Rated by John Wilkin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Initiates: Buy | $12 | $6.10 | +96.72% | 1 | Jul 23, 2025 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $15 | $16.24 | -7.64% | 1 | Jun 18, 2025 | |
| VCYT Veracyte | Initiates: Buy | $45 | $42.10 | +6.89% | 1 | Mar 20, 2025 | |
| PSNL Personalis | Initiates: Buy | $8 | $7.96 | +0.50% | 1 | Mar 17, 2025 | |
| MYGN Myriad Genetics | Initiates: Buy | $29 | $6.15 | +371.54% | 1 | Feb 12, 2025 |
Exagen
Jul 23, 2025
Initiates: Buy
Price Target: $12
Current: $6.10
Upside: +96.72%
Adaptive Biotechnologies
Jun 18, 2025
Initiates: Buy
Price Target: $15
Current: $16.24
Upside: -7.64%
Veracyte
Mar 20, 2025
Initiates: Buy
Price Target: $45
Current: $42.10
Upside: +6.89%
Personalis
Mar 17, 2025
Initiates: Buy
Price Target: $8
Current: $7.96
Upside: +0.50%
Myriad Genetics
Feb 12, 2025
Initiates: Buy
Price Target: $29
Current: $6.15
Upside: +371.54%